US HB2891 | 2021-2022 | 117th Congress

Status

Spectrum: Slight Partisan Bill (Democrat 5-3)
Status: Introduced on April 28 2021 - 25% progression, died in chamber
Action: 2021-09-29 - Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 28 - 13.
Text: Latest bill text (Introduced) [PDF]

Summary

To prohibit prescription drug companies from compensating other prescription drug companies to delay the entry of a generic drug, biosimilar biological product, or interchangeable biological product into the market.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Preserve Access to Affordable Generics and Biosimilars Act

Sponsors


History

DateChamberAction
2021-09-29HouseOrdered to be Reported in the Nature of a Substitute by the Yeas and Nays: 28 - 13.
2021-09-29HouseCommittee Consideration and Mark-up Session Held.
2021-04-29HouseReferred to the Subcommittee on Health.
2021-04-28HouseReferred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2021-04-28HouseIntroduced in House

Same As/Similar To

SB1428 (Related) 2021-12-09 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 180.
HB5260 (Related) 2022-11-01 - Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
HB5237 (Related) 2022-11-01 - Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.

Subjects


US Congress State Sources


Bill Comments

feedback